Alopecia Areata Latest Advances

Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.

Journal: Integrative medicine (Encinitas, Calif.)

Published: April 09, 2026

Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study.

Journal: The Journal of dermatological treatment

Published: April 01, 2026

Beyond hair loss: Exploring the link between alopecia areata and non-alcoholic fatty liver disease.

Journal: Tropical doctor

Published: March 31, 2026

Comorbidities in Pediatric Patients With Alopecia Areata: A Systematic Review and Meta-Analysis.

Journal: Journal of cutaneous medicine and surgery

Published: March 30, 2026

Dynamics of Lipid Profile in Patients With Alopecia Areata Treated With Ritlecitinib: A Descriptive, Retrospective, Real-World Study.

Journal: Journal of cutaneous medicine and surgery

Published: March 27, 2026

Stepwise topical corticosteroid and dexamethasone rescue strategy enhances baricitinib outcomes in severe alopecia areata: real-life clinical experience.

Journal: European journal of dermatology : EJD

Published: March 23, 2026

Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study.

Journal: JAAD international

Published: March 20, 2026

Scalp Alopecia After Greater Occipital Nerve Block Administration Mimicking Alopecia Areata.

Journal: The American Journal of dermatopathology

Published: March 18, 2026

Correction to The burden of alopecia areata among United States, 2000-2021: A systematic analysis for the Global Burden of Disease Study 2021 [Journal of the American Academy of Dermatology. 2025 Dec;93(6)1619-1621].

Journal: Journal of the American Academy of Dermatology

Published: March 18, 2026

Real-World Efficacy of Ritlecitinib in Adolescent Patients With Alopecia Areata: A 36 Week Monocentric Real-Life Observational Study.

Journal: Journal of cutaneous medicine and surgery

Published: March 12, 2026

Effective treatment of alopecia areata and psoriasis with baricitinib.

Journal: The British journal of dermatology

Published: March 11, 2026

Efficacy of Dupilumab in Treating Trachyonychia and Other Nail Dystrophies: A Systematic Review of Case Reports.

Journal: Cureus

Published: March 06, 2026

Alopecia Areata Latest Advances

Find the Latest Research About Alopecia Areata

Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.

Successful Remission of Alopecia Areata and Seborrheic Dermatitis in a 21-Year-Old Male via Functional Nutrition and Advanced Diagnostics: A Case Report.

Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study.

Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study.

Beyond hair loss: Exploring the link between alopecia areata and non-alcoholic fatty liver disease.

Beyond hair loss: Exploring the link between alopecia areata and non-alcoholic fatty liver disease.

Comorbidities in Pediatric Patients With Alopecia Areata: A Systematic Review and Meta-Analysis.

Comorbidities in Pediatric Patients With Alopecia Areata: A Systematic Review and Meta-Analysis.

Dynamics of Lipid Profile in Patients With Alopecia Areata Treated With Ritlecitinib: A Descriptive, Retrospective, Real-World Study.

Dynamics of Lipid Profile in Patients With Alopecia Areata Treated With Ritlecitinib: A Descriptive, Retrospective, Real-World Study.

Stepwise topical corticosteroid and dexamethasone rescue strategy enhances baricitinib outcomes in severe alopecia areata: real-life clinical experience.

Stepwise topical corticosteroid and dexamethasone rescue strategy enhances baricitinib outcomes in severe alopecia areata: real-life clinical experience.

Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study.

Increased risk of hair loss with GLP-1 receptor agonists: A real-world multicenter TrinetX cohort study.

Scalp Alopecia After Greater Occipital Nerve Block Administration Mimicking Alopecia Areata.

Scalp Alopecia After Greater Occipital Nerve Block Administration Mimicking Alopecia Areata.

Correction to The burden of alopecia areata among United States, 2000-2021: A systematic analysis for the Global Burden of Disease Study 2021 [Journal of the American Academy of Dermatology. 2025 Dec;93(6)1619-1621].

Correction to The burden of alopecia areata among United States, 2000-2021: A systematic analysis for the Global Burden of Disease Study 2021 [Journal of the American Academy of Dermatology. 2025 Dec;93(6)1619-1621].

Real-World Efficacy of Ritlecitinib in Adolescent Patients With Alopecia Areata: A 36 Week Monocentric Real-Life Observational Study.

Real-World Efficacy of Ritlecitinib in Adolescent Patients With Alopecia Areata: A 36 Week Monocentric Real-Life Observational Study.

Effective treatment of alopecia areata and psoriasis with baricitinib.

Effective treatment of alopecia areata and psoriasis with baricitinib.

Efficacy of Dupilumab in Treating Trachyonychia and Other Nail Dystrophies: A Systematic Review of Case Reports.

Efficacy of Dupilumab in Treating Trachyonychia and Other Nail Dystrophies: A Systematic Review of Case Reports.